Results 181 to 190 of about 234,888 (250)

CCL22 as a diagnostic and prognostic biomarker for pediatric-onset systemic lupus erythematosus. [PDF]

Clin Exp Med
Chen XL, Liu CX, Huang MK, Hui L, Liu T, Jiang YM.   +5 more
europepmc   +1 more source

IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets

Allergy, EarlyView.
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco, Syed B. Ali, Baran Erman, Safa Baris, Harshita Pant, Pravin Hissaria, Yelda Bilginer, Damon J. Tumes, Gökhan Cildir   +8 more
wiley   +1 more source

Systemic lupus erythematosus with recurrent posterior reversible encephalopathy syndrome: A rare case report. [PDF]

Medicine (Baltimore)
Chen B, Hong H, Wang J, Li X, Wang C, Xie T.   +5 more
europepmc   +1 more source

Placental growth factor before 11 weeks for screening of preterm preeclampsia: The PreMoM study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
In this multicenter study including 3448 women with singleton pregnancies in Spain, early placental growth factor (PlGF) measurement (<11 weeks) was compared with standard timing (11–13 weeks) for preterm preeclampsia screening. Early measurements showed no added benefit over models without PlGF.
Rocío López Mármol, José Alejandro Ávila Cabreja, Teresa de Haro Romero, Catalina de Paco Matallana, Olga Ocón Hernández, Otilia González‐Vanegas, Pilar Carretero Lucena, María Paz Carrillo, Juan Luis Delgado, Valeria Rolle, Uzay Gormus, Liza Oraha, María M. Gil, Francisca S. Molina   +13 more
wiley   +1 more source

Wolf and the Dagger: A Rare Overlap. [PDF]

Cureus
Tammana M, Patnaik SS, Parida MK, Tripathy SR, Das BK.   +4 more
europepmc   +1 more source

Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors

Rheumatology &Autoimmunity, EarlyView.
Lifang Wang, Yan Ding, Lei Wang, Lianjie Shi   +3 more
wiley   +1 more source

The Aetiology of Elevated Total Serum Immunoglobulin E in Children

Acta Paediatrica, EarlyView.
ABSTRACT Aim The paucity of real‐world data on the aetiology of elevated total serum immunoglobulin E (TS‐IgE) in children afflicts families and health care systems with diagnostic uncertainty. We explored a cohort of children with TS‐IgE levels over 1000 kU/L, focusing on the prevalence of atopic and non‐atopic conditions, the aetiology of extremely ...
Aliisa Ärölä, Kaarina Kukkonen, Svetlana Vakkilainen   +2 more
wiley   +1 more source

Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis. [PDF]

Sci Rep
Alves L, Lemos AP, Martins J, da Costa Fonseca S, Gaudio RC, Lima H, Carvalho C, Ramos A, de Souza Lacerda G, da Fonseca PB, De Felice FG, Cabral-Castro MJ, de Matos JPS, Almeida JR, Burger D, Medeiros T, Silva AA.   +16 more
europepmc   +1 more source

Diagnostics of Autoimmune Hepatitis Enabled by Non‐Invasive Clinical Proteomics

Alimentary Pharmacology &Therapeutics, EarlyView.
Mass‐spectrometry‐based proteomic analyses of paired liver‐plasma samples from patients with AIH enabled discovery of numerous proteins showing high diagnostic accuracy. Proteomics may constitute a novel non‐invasive diagnostic tool for AIH if validated in larger, age‐ and sex‐matched cohorts.
Anne‐Sofie Houlberg Jensen, Henriette Ytting, Annelaura Bach Nielsen, Mikkel Parsberg Werge, Elias Badal Rashu, Liv Eline Hetland, Mira Thing, Puria Nabilou, Johan Burisch, Anders Ellekær Junker, Lise Hobolth, Christian Mortensen, Flemming Tofteng, Flemming Bendtsen, Søren Møller, Mogens Vyberg, Reza Rafiolsadat Serizawa, Marie Winther‐Sørensen, Jesper Sloth Kellemann, Lise Lotte Gluud, Nicolai Jacob Wewer Albrechtsen   +20 more
wiley   +1 more source

Predictors of response to emergent therapies in paediatric immune thrombocytopenia

British Journal of Haematology, EarlyView.
Emergent therapies (ET), which include intravenous immunoglobulin (IVIG), corticosteroids and intravenous anti‐Rho(D) immunoglobulin, are used to treat acute episodes of bleeding in children with immune thrombocytopenia (ITP). Through comparison of clinical characteristics in paediatric patients with ITP responsive to ET versus those non‐responsive to ...
Candelaria O'Farrell, Taylor M. Luckie, Matthew J. Willis, Susan E. Kirk, Brandon R. Lucari, Michael E. Scheurer, Xiaotian Gao, Amanda B. Grimes   +7 more
wiley   +1 more source